Global Veterinary Medicine Market Research Report

1. Global Veterinary Medicine Market Size– Forecasts to 2026 According to GME analysis, the Global Veterinary Medicine Market will register a CAGR value of 7.65% between 2021-2026. Veterinary medicines are used to treat diseases and improve the quality of life of animals. Rising awareness of animal healthcare among people and the growing animal rights concerns have played a significant role in the growth of the veterinary medicines market. Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on "Veterinary Medicine Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-veterinary-medicine-market-2651 By Product (Biologics, Medicated Feed Additives, Pharmaceuticals), By Animal Type (Companion, Production), By Mode of Delivery (Oral, Parenteral), By End-User (Point-of-care Testing/ In-house Testing, Reference Laboratories, Veterinary Hospitals & Clinics), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis Key Market Insights The increasing investments in animal healthcare and a growing number of pet owners are supporting the market growth. Veterinary hospitals & clinics held the largest market share while the reference laboratories segment showed the fastest growth rate In January 2021, Vetoquinol acquired the rights for Drontal and Profender de-wormer medicines in the Australian market from Elanco Animal Health Inc. Kindredbio, Bayer AG, Virbac, BiogénesisBagó, Zoetis, BoehringerIngelheim, Vetoquinol, Ceva Santé Animale, Nutreco, Elanco Animal Health Inc., Neogen Corporation, Hester Biosciences Limited, Merck Animal Health, Indian Immunologicals Limited are some of the leading companies in the global veterinary medicines market. Browse the Report @ https://www.globalmarketestimates.com/market-report/global-veterinary-medicine- market-2651 Product Outlook (Revenue, USD Billion, 2021-2026) Biologics DNA vaccines

2. Inactivated vaccines Live attenuated vaccines Recombinant vaccines Vaccines Medicated Feed Additives Pharmaceuticals Analgesics Anti-infectives Anti-inflammatory Parasiticides Animal Type Outlook (Revenue, USD Billion, 2021-2026) Companion Cats Dogs Horses Production Cattle Poultry Fish Sheep & Goat Swine Mode of Delivery Outlook (Revenue, USD Billion, 2021-2026) Oral Parenteral End-User Outlook (Revenue, USD Billion, 2021-2026) Point-of-care Testing/ In-house Testing Reference Laboratories Veterinary Hospitals & Clinics Regional Outlook (Revenue, USD Billion, 2021-2026) North America The U.S. Canada

3. Mexico Europe Germany UK France Spain Italy Rest of Europe Asia Pacific China India Japan South Korea Australia Rest of APAC Central & South America Brazil Argentina Rest of CSA Middle East & Africa Saudi Arabia UAE Rest of MEA Contact: Tracy Simon Email address: tracy.simon@globalmarketestimates.com Phone Number: +16026667238 Website: https://www.globalmarketestimates.com/

4. Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php